I am wondering what the IP separation is like with DROWZLE, I have read the sleep apnoea patent for ResApp from UQ researcher. Seems a little too specific to shield out this product. I guess it is a head to head competition, 2 products based on similar no overlapping technologies?
- Forums
- ASX - By Stock
- RAP
- Ann: At-Home Obstructive Sleep Apnoea Study Update
Ann: At-Home Obstructive Sleep Apnoea Study Update, page-199
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)